
Atherosclerosis and its Role in the Immune System
Learn how the leading cause of death worldwide activates the immune system and how making a few lifestyle changes can decrease your risk of severe chronic disease.
Showing results for: "immune system" (88 results)

Learn how the leading cause of death worldwide activates the immune system and how making a few lifestyle changes can decrease your risk of severe chronic disease.

Ageing is accompanied by a gradual decline in physiological functions, among which deterioration of the immune system termed immunosenescence—has profound implications for human health.

Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.

Bacterial lysates and postbiotics can train your immune system to prevent respiratory infections. Here is why they matter in the era of antibiotic resistance.

In Sci-fi visions of distant futures, some imagine sprawling intergalactic civilizations. Scaffolds built around stars harvesting their energy. Fusion reactors, cyborgs, superintelligent implants. But the future of artificial bones, though perhaps more mundane, could be a life saving science.

Explore the multi-organ cellular mapping of GLP-1 receptor agonists. Discover how GLP-1RAs act as a systemic shield across T2DM, obesity, PMOS, MASH and so on.

Inhalable vaccines trigger powerful mucosal immunity where pathogens enter the body, offering needle-free protection against respiratory diseases.

Drug repurposing is reshaping medicine. Discover how changing a drug's route of administration — not the molecule itself — can unlock new therapeutic potential.

Modern healthcare is undergoing a silent revolution. Now to treat a disease in the healthcare system, there is no longer a need to wait for symptoms to appear.

Messenger RNA (mRNA) vaccines represent one of the most significant scientific advances in modern therapeutics. Unlike conventional vaccines that use weakened or inactivated pathogens, mRNA vaccines deliver genetic instructions that enable host cells to synthesize a target antigen and stimulate an immune response.

Cell and gene therapies represent a seismic shift in healthcare. They promise to cure the incurable, restoring sight to the blind and erasing cancer from the blood. But this frontier is wild. It comes with biological price tags, potential genetic misfires, and a regulatory landscape that is still being mapped.

Why is mucus the biggest obstacle to lung drug delivery? Explore the mucosal barrier science reshaping how we design inhaled medicines and vaccines.

Inhaled antibiotics deliver drugs directly to lung infections, achieving better results with fewer side effects, which is a game-changer in fighting resistance.

Many physical and computational systems exhibit a familiar behavior: ordered states gradually decay in the presence of noise. Examples appear across science:

Vaccines need precise temperature control to work but maintaining the cold chain wastes half of all doses globally. New thermostable formulations could change everything.

Animal models have traditionally served as the cornerstone of drug safety evaluation; however, major translational challenges persist due to interspecies differences in physiology, metabolism, and genetic regulation. Many compounds demonstrating favorable toxicity profiles in animals later fail during human trials or are withdrawn post-marketing due to unforeseen adverse effects, especially hepatotoxicity and cardiotoxicity (Lee et al., 2025).

Smart nanoparticles are an exciting step forward in modern medicine especially nanomedicine. They help doctors be more precise in cancer treatment.

How a 150-year-old food industry technique became essential for creating stable biologics and inhaled medicines, transforming liquid drugs into life-saving powders.

This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.

In this study, I explore how cancer risk is distributed across the animal kingdom, emphasizing the role of life-history traits, reproductive strategies, and social behavior in shaping susceptibility to disease. Drawing on recent findings in comparative oncology, the article examines patterns that challenge traditional assumptions, such as the relationship between body size and cancer, and highlights evolutionary mechanisms that may confer resistance in certain species.